1. The Pharmacist may not dispense prescriptions that include Pharmaceutical Products containing narcotic substances or psychotropic substances in accordance with Federal Decree-Law No. (30) of 2021 referred to, unless they meet the following conditions: a. The prescription shall be issued from the electronic system stipulated in accordance with the provisions of Federal Decree-Law No. (30) of 2021 referred to. b. The prescription shall include the name of the commercial Pharmaceutical Product, the scientific name of the active ingredient, the amount of the Pharmaceutical Product, the dose in numbers and letters, the method and term of its use, the patient full name, age, address, and any other requirements required for registration on the Narcotic and Psychotropic Substances Tracking Platform. c. The prescribed dose shall not exceed what is stated in the scientific references used in the EDE. 2. A prescription for controlled Medical Products may not be dispensed if a period of time has elapsed since it was issued exceeding the period specified in the Executive Regulations of this Decree-Law.
Interpretation and application must be checked against the official text and current version.